NCT00333840 2013-10-14
Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Novartis
Phase 3 Completed
Novartis
Pfizer
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Pfizer
sigma-tau i.f.r. S.p.A.